文献速递头颈与中枢神经肿瘤

昼夜节律调节因子CLOCK招募免疫抑制性小胶质细胞进入胶质母细胞瘤微环境

Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment.
PubMed 文献 · Cancer Discov · 2020-01-09

该研究通过功能获得性筛选发现昼夜节律调节因子CLOCK可增强胶质瘤干细胞自我更新,并在约5%的人胶质母细胞瘤中扩增。CLOCK与BMAL1通过转录上调新型趋化因子OLFML3招募免疫抑制性小胶质细胞,敲低CLOCK或OLFML3可降低瘤内小胶质细胞密度并延长总生存期,提示CLOCK-BMAL1及OLFML3为潜在治疗靶点。

要点

  • CLOCK在约5%的人GBM中扩增,增强胶质瘤干细胞自我更新。
  • CLOCK-BMAL1转录上调OLFML3,招募免疫抑制性小胶质细胞。
  • 敲低CLOCK或OLFML3降低瘤内小胶质细胞密度并延长生存。

核心结论

  • CLOCK-BMAL1复合物通过上调OLFML3维持胶质瘤干细胞自我更新并促进免疫抑制,是GBM的潜在治疗靶点。

研究设计与样本

  • 研究对可能影响胶质瘤干细胞自我更新和肿瘤免疫的表观遗传调节因子进行功能获得性筛选。

主要发现

  • CLOCK在增强干细胞自我更新中排名靠前,并在约5%的人GBM病例中扩增。
  • CLOCK及其异二聚体伙伴BMAL1增强胶质瘤干细胞自我更新,并通过转录上调OLFML3触发促肿瘤免疫。
  • 在GBM模型中,敲低CLOCK或OLFML3降低瘤内小胶质细胞密度并延长总生存期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Glioblastoma (GBM) is a lethal brain tumor containing a subpopulation of glioma stem cells (GSC). Pan-cancer analyses have revealed that stemness of cancer cells correlates positively with immunosuppressive pathways in many solid tumors, including GBM, prompting us to conduct a gain-of-function screen of epigenetic regulators that may influence GSC self-renewal and tumor immunity. The circadian regulator CLOCK emerged as a top hit in enhancing stem-cell self-renewal, which was amplified in about 5% of human GBM cases. CLOCK and its heterodimeric partner BMAL1 enhanced GSC self-renewal and triggered protumor immunity via transcriptional upregulation of OLFML3, a novel chemokine recruiting immune-suppressive microglia into the tumor microenvironment. In GBM models, CLOCK or OLFML3 depletion reduced intratumoral microglia density and extended overall survival. We conclude that the CLOCK-BMAL1 complex contributes to key GBM hallmarks of GSC maintenance and immunosuppression and, together with its downstream target OLFML3, represents new therapeutic targets for this disease. SIGNIFICANCE: Circadian regulator CLOCK drives GSC self-renewal and metabolism and promotes microglia infiltration through direct regulation of a novel microglia-attracting chemokine, OLFML3. CLOCK and/or OLFML3 may represent novel therapeutic targets for GBM.This article is highlighted in the In This Issue feature, p. 327.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Chen P, Hsu WH, Chang A, et al. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment. Cancer Discov. 2020. PMID: 31919052. doi:10.1158/2159-8290.CD-19-0400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。